JP Morgan Chase
VKTX icon

JP Morgan Chase’s Viking Therapeutics VKTX Stock Holding History

JP Morgan Chase’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-30,000
Closed -$898K – 8111
2026
Q1 		$898K Buy
+30,000
New +$964K ﹤0.01% 4671
2025
Q4 		– Sell
-29,700
Closed -$781K – 7806
2025
Q3 		$781K Sell
29,700
-20,600
-41% -$615K ﹤0.01% 4757
2025
Q2 		$1.33M Sell
50,300
-13,900
-22% -$366K ﹤0.01% 4208
2025
Q1 		$1.55M Sell
64,200
-665,800
-91% -$21M ﹤0.01% 4047
2024
Q4 		$29.4M Buy
730,000
+360,000
+97% +$20.5M ﹤0.01% 1685
2024
Q3 		$23.4M Buy
370,000
+190,000
+106% +$11.1M ﹤0.01% 1857
2024
Q2 		$9.54M Buy
180,000
+85,900
+91% +$5.63M ﹤0.01% 2503
2024
Q1 		$7.72M Buy
+94,100
New +$4.19M ﹤0.01% 2722
2023
Q4 		– Sell
-60,000
Closed -$664K – 7896
2023
Q3 		$664K Sell
60,000
-83,200
-58% -$1.19M ﹤0.01% 4318
2023
Q2 		$2.32M Buy
+143,200
New +$3M ﹤0.01% 3436
2023
Q1 		– Sell
-20,000
Closed -$188K – 7255
2022
Q4 		$188K Buy
+20,000
New +$89.3K ﹤0.01% 5066
2019
Q2 		– Sell
-7,300
Closed -$73K – 6034
2019
Q1 		$73K Buy
+7,300
New +$61.1K ﹤0.01% 4995

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

JP Morgan Chase's VKTX Position: Q2 2026 in Review

JP Morgan Chase increased its Viking Therapeutics (VKTX) stake by 88% in Q2 2026, buying an estimated $13.9M and bringing the position to 915,185 shares worth $36.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1709.

JP Morgan Chase first reported a position in VKTX in Q2 2018 and has held it in 33 quarters since. The position peaked at $134M in Q3 2024. 436 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • JP Morgan Chase held 915,185 shares of Viking Therapeutics worth $36.4M as of Q2 2026.
  • JP Morgan Chase bought 429,482 Viking Therapeutics shares in Q2 2026, an estimated $13.9M.
  • Viking Therapeutics made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #1709 holding.
  • JP Morgan Chase first reported a position in Viking Therapeutics in Q2 2018 and has held it in 33 quarters since.
  • JP Morgan Chase's Viking Therapeutics position peaked at $134M in Q3 2024.
  • 436 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.